Fructobacillus Culturing for Nicotinamide Riboside Production

Solution Overview

Problem

Current microbiological processes for producing nicotinamide mononucleotide and nicotinamide riboside have limitations in terms of production efficiency.

Innovation Solution

Culturing lactic acid bacteria from the genus Fructobacillus, specifically strains like Fructobacillus durionis, Fructobacillus tropaeoil, and Fructobacillus fructosus, in optimized culture media to enhance the production of both nicotinamide mononucleotide and nicotinamide riboside.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional microbiological processes are used to produce nicotinamide mononucleotide or nicotinamide riboside, then production can be achieved, but production efficiency is insufficient

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent changes the microbial host from conventional bacteria (E. coli, B. subtilis) to lactic acid bacteria (Fructobacillus species), and optimizes culture conditions including pH control (maintaining pH 5.0-6.0), temperature (30-37°C), and carbon source composition. These parameter changes result in significantly improved production efficiency and yield of nicotinamide riboside, resolving the technical contradiction between conventional processes and production efficiency requirements.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If a single microorganism is used for production, then process simplicity is maintained, but the ability to produce both nicotinamide mononucleotide and nicotinamide riboside simultaneously is limited

Engineering Contradiction:
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent identifies lactic acid bacteria (particularly Fructobacillus durionis, Fructobacillus tropaeoli, and Fructobacillus fructosus) that possess multi-functional metabolic pathways enabling them to produce both nicotinamide mononucleotide and nicotinamide riboside simultaneously from the same culture medium. This single microorganism system achieves dual product production without requiring separate fermentation processes, thereby maintaining process simplicity while enhancing adaptability and versatility.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly increases the production efficiency of nicotinamide riboside and allows for the simultaneous production of nicotinamide mononucleotide, making them suitable for use in food supplements and other applications.

Implementation Method 1

a process for producing nicotinamide riboside, comprising the step of culturing a lactic acid bacteria belonging to the genus Fructobacillus to prepare a culture containing nicotinamide riboside

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS20240376508A1Lactic acid bacteria that produce nicotinamide riboside, and lactic acid bacteria that produce nicotinamide mononucleotide and nicotinamide riboside
Publication Date: 2024.11.14

AI summary

Microorganisms which efficiently produce nicotinamide riboside, and microorganisms which can efficiently produce both nicotinamide mononucleotide and nicotinamide riboside. Nicotinamide mononucleotide and nicotinamide riboside can be produced by culturing lactic acid bacteria belonging to the genus Fructobacillus.